NCT02686294View on ClinicalTrials.gov

Repeated Dosing Clinical Trial of HL151

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 16, 2016

Primary Completion Date

March 15, 2016

Study Completion Date

March 15, 2016

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

HL151

Test drug : HL151. 1T, once a day oral administration, for 4 days

DRUG

TALION tab.

Reference drug : TALION tab. 1T, twice a day oral administration, for 4 days

Trial Locations (1)

136-705

The Korea Univertisy Anam Hospital, Seoul

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT02686294 - Repeated Dosing Clinical Trial of HL151 | Biotech Hunter | Biotech Hunter